Resilience amid transition: 11% growth masks margin miss and seasonal weakness
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade C
Missed adjusted net margin guidance (16% vs 21% expected); deferred full-year revenue guidance; implementation recovery dependent on customer project ramps.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Newgen delivered resilient YoY growth (11% revenue, 26% PAT) and strong subscription momentum (+40%), but the quarter is softer than headlines suggest: QoQ revenue fell 21% and PAT 41%, NPM fell to 16% vs 21% prior guidance, and implementation revenue collapsed amid project delays. CEO transition and margin guidance (23–25% EBITDA target vs Q1 15.7%) add execution risk. Subscription shift and AI roadmap are structural positives, but near-term recovery is contingent.
₹357 Cr
Revenue · +11.2% YoY₹63 Cr
Reported PAT · +26.3% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Revenue ₹357 Cr, 11% YoY growth, net margin 17.6%
OVERSTATEDRevenue 356.7 Cr confirmed; YoY 11.2% confirmed; but NPM 16.0% delivered vs 17.6% claimed
EBITDA margin 15.7%, on track for 23–25% full year
MixedQ1 EBITDA 15.7% correct; but historical pattern and macro uncertainty make 23–25% FY target ambitious
Implementation revenue will recover ₹12 Cr shortfall in Q2–Q3
PartialManagement optimistic but implementation revenue down ~25% QoQ; contingent on project ramp; contingency risk
Subscription/SaaS growing 40% YoY to ₹60 Cr annualized
METConsistent with stated ₹60 Cr quarterly; 40% YoY growth confirmed. Positive data point.
Earnings quality
What changed since the last call
CEO leadership transition
NewVirender Jeet stepping down; Tarun Nandwani (COO, 33 yrs tenure) assumes CEO effective Aug 1. Pramod appointed Chief Growth Officer. Execution risk.
Implementation revenue trajectory
DowngradeQ1 implementation revenue declined ~₹12 Cr QoQ due to EMEA project start delays. Management expects recovery in Q2–Q3; contingency remains.
India margin guidance
DowngradeIndia revenue flat YoY at ₹96 Cr; base costs up 4–5%. Management initially guided 21% adj net margins; Q1 delivered 16%. India margin squeeze continues.
Full-year margin outlook
MixedManagement targets 23–25% full-year EBITDA (vs Q1 15.7%, implying significant recovery). Ambitious given FY26 prior miss and macro uncertainty.
Subscription/SaaS acceleration
UpgradeSaaS/subscription revenue reached ₹60 Cr (+40% YoY), up from ₹43 Cr prior year. Now 17% of revenue; trajectory positive.
The Q&A
Analysts pressed on implementation revenue decline (Aditi Patil, Sonal), margin guidance credibility (Shubhi Gupta, Vijay Menon), and India/EMEA recovery timing. Management held firm on pipeline health and blamed project delays on customer environments, not internal execution. No push-back on CEO transition or prior guidance miss. Moderate pressure, evasive on specifics (no RPO disclosure, no FY27 revenue guidance).
EBITDA margin expansion drivers — Shubhi Gupta, Trinetra Asset Management
PartialTarun: Margin expansion from AI optimization in engineering practices; efficiency gains passed to customers for faster implementations. Management: Q1 is lowest margin quarter; full year typically 23–25% EBITDA.
Implementation revenue decline — Aditi Patil, ICICI Securities
AnsweredTarun: FY26 had lower license, but Q1 had good license bump. Impl revenue built from unexecuted order book + current quarter orders. Delays from customer environment, esp. India/EMEA. Expect Q2–Q3 recovery.
India & EMEA outlook — Aditi Patil, ICICI Securities
AnsweredTarun: Pipeline healthy in both. India: large NBFC/LOS/LMS/trade deals coming. EMEA: digital transformation, AI-led tools, SaaS. Mature markets subscription-based, continued growth.
DSO/collections — Aditi Patil, ICICI Securities
PartialTarun: DSO is recognized challenge; showed decline Q4–Q1. Macro environment in EMEA caused some payment delays. Positive trend expected in coming quarters.
AI demand and competitive positioning — Rahul Jain, Dolat Capital
AnsweredTarun: AI demand strong across all RFPs. Newgen investing in vertical AI (CASA, lending, trade, ECM, etc.). Diversified across geographies/industries cushions macro headwinds.
Headcount and automation — Rahul Jain, Dolat Capital
DodgedTarun: AI benefits as tailwind. Efficiencies in delivery timelines and operational performance broad-based across functions. Customer success remains core focus.
Booking and RPO data — Rahul Jain, Dolat Capital
PartialDeepti/Management: Bookings shared at end of year (March). Pipeline and booking numbers double-digit growth. RPO disclosure may come in future; currently booking growth better parameter.
US growth sustainability — Vijay Menon, Monarch Capital
AnsweredTarun: US mostly subscription-based; prior year wins accrue in coming quarters. Sitting on healthy base with new customer additions and mining. Deepti: 4 large deals disclosed; few in ₹12–16 Cr range, one ₹26 Cr.
Margin guidance — Vijay Menon, Monarch Capital
PartialManagement: Seeing margin expansion. AI optimization driving productivity and growth. Will maintain ~20% margin on annual basis; not appropriate to comment beyond Q1.
Implementation revenue recovery — Sonal, Prescient Capital
AnsweredTarun: Delays from EMEA customer environmental factors. Projects have kicked off; expect Q2–Q3 recovery of ₹12 Cr shortfall and normal run rate.
AI productivity monetization — Sonal, Prescient Capital
PartialTarun: RFPs are fixed-price contracts; AI turnaround efficiencies passed to clients. Operational efficiencies accrue to Newgen on impl revenue. Support revenue split across large base; minimal demand pressure.
Full-year revenue guidance — Sonal, Prescient Capital
DodgedManagement: No specific revenue guidance for company of this size. Hopeful for improved growth vs FY26. Targeting double-digit growth continuation.
Deal win rate and Middle East — Sanjay, SKS Securities
AnsweredTarun: Deal count quarter-to-quarter varies; deal size grown substantially (₹15–16+ Cr deals). Middle East: UAE/Qatar/Kuwait mining deals strong. New deals from region. Africa/Europe also showing good pipeline.
Capital allocation (M&A, buyback, dividend) — Sanjay, SKS Securities
PartialManagement: M&A under deliberation for years; finding right fit takes time. Dividend optimization ongoing. Buyback input given to Board; working on it.
License vs SaaS revenue mix — Tushar, Shanghvi Family Office
AnsweredTarun: License mostly from India/EMEA. Mature markets mostly subscription. Delays in India/EMEA deal closures impact license. Pipeline healthy; recovery expected.
Deal ramp-up timing — Tushar, Shanghvi Family Office
AnsweredTarun: Large India/EMEA deals: license + impl within 1 year. Impl recognized in 12–18 months. Others subscription (quarterly recognition).
Long-term revenue and margin targets — Tushar, Shanghvi Family Office
DodgedTarun: Strategy focused on customer success, innovation investment. Consistency and resilience in margins even with lower growth. No specific targets given.
AI pricing model evolution — Shaurya Yadav, Growthsphere Ventures
PartialTarun: Evolved pricing for AI vertical offerings; remains work in progress. Trade, insurance, RMS, ECM pricing getting established. Will evolve as sales increase.
Customer decision-making on AI — Shaurya Yadav, Growthsphere Ventures
AnsweredTarun: Central banks publishing AI regulations. Customer ready to implement AI within compliance framework. This is sweet spot for Newgen. Seeing AI-based deal wins.
Guidance
No specific FY27 revenue guidance provided
N/AManagement deferred; cited company size and macro uncertainty. Aspires to double-digit growth continuation vs FY26.
Full-year EBITDA target 23–25%; Q1 15.7% lowest of year
MediumImplies significant recovery in Q2–Q4. Ambitious given prior miss (21% adjusted net margin not achieved). Contingent on implementation recovery and cost control.
Risks the call surfaced
Implementation revenue cycle
HighImplementation revenue fell ~₹12 Cr QoQ due to EMEA project start delays. Management claims recovery in Q2–Q3, but project ramp contingent on customer execution. Risk of further delays into Q4.
India margin compression
MediumIndia revenue ₹96 Cr flat YoY; base costs up 4–5%. Margin squeeze evident. No concrete plan to restore growth; recovery timing vague (later quarters).
Margin guidance credibility
MediumManagement targets 23–25% EBITDA full-year; Q1 delivered 15.7%. Implies Q2–Q4 avg ~26–28% EBITDA to hit midpoint. Aggressive given prior miss (21% adj net margin not achieved in FY26).
CEO transition risk
MediumVirender Jeet (CEO) stepping down; Tarun Nandwani (COO, 33 yrs) assumes effective Aug 1. While Tarun is long-tenured, transition occurs amid weaker quarter and margin miss. No clarity on strategic direction shifts.
License revenue dependency
MediumLicense revenue concentrated in India/EMEA; highly dependent on large deal closures. Delays in Q1 (project starts slow); recovery assumes Q2–Q4 closures materialize.
DSO / working capital
LowDSO management remains a challenge; macro environment in EMEA caused payment delays in Q1. Positive trend expected, but no specific timeline.
Management
Score 6/10. Management is cautious and selective in disclosure. No full-year revenue guidance given; margin targets stated but without detail on mechanics. Evasive on RPO data and specific recovery timelines. Mixed. Delivered 11% YoY growth and 26% YoY PAT growth, but missed on margins (16% NPM vs 21% prior guidance, -5 pts shortfall) and saw steep QoQ decline (-21% revenue, -41% PAT). Implementation revenue recovery not yet proven.
1 · Q2 FY27
Recovery of ₹12 Cr implementation revenue; project ramp-ups in EMEA
2 · Aug 1, 2026
Tarun Nandwani assumes CEO; Virender Jeet departs
3 · FY27 full year
Execution on 23–25% EBITDA margin target; SaaS/subscription reach >18–20% of revenue mix
Subscription shift and AI roadmap are structural positives, but near-term recovery is contingent.
Newgen Q1: consolidated PAT +26% YoY to ₹62.8 Cr on margin expansion, US-led growth
PAT +26.35% YoY · revenue +11.23% · margins expanding
₹356.68 Cr
+11.23% YoY
₹62.82 Cr
+26.35% YoY
15.99%
+1.8pp YoY
₹4.44
Newgen Software reported a clean, profit-led first quarter on a consolidated basis: revenue from operations of ₹356.68 Cr rose 11.2% YoY (from ₹320.66 Cr) while net profit jumped 26.4% to ₹62.82 Cr (from ₹49.72 Cr), lifting net margin (on total income) to 16.0% from 14.2% a year ago. With no exceptional items on either Q1, the YoY comparison is like-for-like — the +26% PAT print is fully underlying, not flattered by one-offs. The sequential optics are weak (revenue −21.2%, PAT −40.9% vs Q4), but Q4 is Newgen's seasonally strongest quarter for IT-services license closures, so the QoQ drop is a seasonality artifact rather than a deterioration.
Q1 FY-2027 vs prior quarters
The growth was driven by overseas markets, consistent with management's stated pivot: consolidated USA revenue rose ~27% YoY to ₹91.51 Cr and EMEA ~12% to ₹113.63 Cr, while India was flat at ₹95.61 Cr — the exact India-slowdown/US-APAC-offset dynamic flagged on the Q4 call. Operating leverage on this mix expanded segment profitability, with employee cost and other expenses growing slower than the overseas topline. Standalone (parent-only) grew more modestly — revenue +8.5% to ₹304.36 Cr, PAT +22.7% to ₹59.77 Cr — so the ~3-4pp higher consolidated growth confirms subsidiaries (US/APAC) are carrying the acceleration; readers seeing the standalone number elsewhere should not treat it as contradictory.
The stock went into the print at ₹555.65, up 16.3% over the past month of trading.
Management refrained from providing specific FY'27 revenue growth guidance due to significant market and geopolitical uncertainty, asking for 1-2 quarters for more clarity. They aim to return to higher growth, driven by a strategic shift to subscription revenues and expansion in the U.S. and APAC markets to offset larg
Against its own framing, the quarter is a partial confirmation. On the Q4 call management refrained from formal FY27 revenue guidance (asking for 1-2 quarters of clarity) but aspired to return toward 15-19% revenue growth and hold adjusted net margins near 21%; Q1's 11.2% YoY is a clear re-acceleration from FY26's ~6% full-year growth yet still below that aspiration, and the ~17.6% net margin on revenue (16.0% on total income) sits under the 21% aim — though Q1 is the weakest seasonal quarter for margins. No street consensus print was published for this small/mid-cap, so vs-estimates is indeterminate. Concurrent with the result, the board confirmed the leadership transition already in our records — Tarun Nandwani as CEO effective 1 August 2026 — against the backdrop of the CMD being indisposed for 45+ days; the ₹26.7 Cr Kuwait, ₹16.18 Cr retail-loan and ₹15.59 Cr Annapurna Finance order wins this quarter are the kind of overseas/BFSI deal flow underpinning the re-acceleration.
What to watch
W1
Revenue trajectory toward management's 15-19% aspiration: Q1's +11.2% YoY must build over the next 1-2 quarters that management asked for before committing to guidance
W2
Net margin path to the ~21% adjusted aim: Q1 landed at ~16-17.6%; watch whether operating efficiency lifts it as seasonally stronger quarters arrive
W3
US/APAC momentum vs flat India: USA +27% YoY carried the quarter — sustained overseas deal wins (post the Kuwait/BFSI orders) are the key driver to verify
Source in ₹ Lakh, converted to Cr (÷100). Clean quarter: NO exceptional items in Q1 FY27 or year-ago Q1 FY26, so YoY is like-for-like. Prior-year exceptionals (Labour Codes, Qatar legal provision) sat only in Q4/FY26, affecting QoQ base. No minority interest (100% owned subsidiaries). Statements crisp and legible.